CHRISTINE HUNT: Open Payments
NPI 1801253885 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,970 in 70 payments from 18 companies in 2025. Trend: 2023 $2,305 · 2024 $3,358 · 2025 $2,970
Food & beverage: $2,970
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 25 | $406 |
| Lundbeck LLC | 9 | $367 |
| Viatris Specialty LLC | 12 | $317 |
| E.R. Squibb & Sons, L.L.C. | 4 | $293 |
| Abbott Laboratories | 2 | $273 |
| Teva Pharmaceuticals USA, Inc. | 2 | $232 |
| Axsome Therapeutics, Inc. | 2 | $222 |
| ACADIA Pharmaceuticals Inc | 2 | $156 |
| Amgen Inc. | 1 | $137 |
| Neurocrine BioSciences, Inc. | 1 | $132 |
Products named: REXULTI, YUPELRI, COBENFY, FREESTYLE LIBRE 3, AUSTEDO XR, Auvelity, NUPLAZID, INGREZZA.
Industry payments across MO — which companies pay providers there.
